The impact of dialysis therapy on older patients with advanced chronic kidney disease: A nationwide population-based study

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Shih, Chia Jen ^a,b   Chen, Yung Tai ^b,c   Ou, Shuo Ming ^a,b   Yang, Wu Chang ^a,b   Kuo, Shu Chen ^a,b,d   Tarng, Der Cherng ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Advanced chronic kidney disease; Conservative care; Dialysis; Older people

Indexed keywords

ANTIANEMIC AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; DIURETIC AGENT;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DECISION MAKING; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH INSURANCE; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN; COST BENEFIT ANALYSIS; ECONOMICS; FACTUAL DATABASE; PUBLIC HEALTH; RENAL INSUFFICIENCY, CHRONIC; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COST-BENEFIT ANALYSIS; DATABASES, FACTUAL; DECISION MAKING; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84908114343     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0169-3     Document Type: Article

References (40)

1. Chu VH, Sexton DJ, Cabell CH, Reller LB, Pappas PA, Singh RK, Fowler VG, Corey GR, Aksoy O, Woods CW. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis 2005, 41:406-409. 10.1086/431590, 16007540.
2. Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 2007, 146:177-183. 10.7326/0003-4819-146-3-200702060-00006, 17283348.
3. Hemmelgarn BR, James MT, Manns BJ, O'Hare AM, Muntner P, Ravani P, Quinn RR, Turin TC, Tan Z, Tonelli M. Rates of treated and untreated kidney failure in older vs younger adults. JAMA 2012, 307:2507-2515. 10.1001/jama.2012.6455, 22797451.
4. Morton RL, Turner RM, Howard K, Snelling P, Webster AC. Patients who plan for conservative care rather than dialysis: a national observational study in Australia. Am J Kidney Dis 2012, 59:419-427. 10.1053/j.ajkd.2011.08.024, 22014401.
5. Smith AK, Walter LC, Miao Y, Boscardin WJ, Covinsky KE. Disability during the last two years of life. JAMA Intern Med 2013, 173:1506-1513. 10.1001/jamainternmed.2013.8738, 23836120.
6. Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, Howard K. Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ 2012, 184:E277-E283. 10.1503/cmaj.111355, 22311947.
7. Moss AH. Revised dialysis clinical practice guideline promotes more informed decision-making. Clin J Am Soc Nephrol 2010, 5:2380-2383. 10.2215/CJN.07170810, 21051749.
8. Kawaguchi T, Karaboyas A, Robinson BM, Li Y, Fukuhara S, Bieber BA, Rayner HC, Andreucci VE, Pisoni RL, Port FK, Morgenstern H, Akizawa T, Saran R. Associations of frequency and duration of patient-doctor contact in hemodialysis facilities with mortality. J Am Soc Nephrol 2013, 24:1493-1502. 10.1681/ASN.2012080831, 23886592.
9. O'Hare AM, Rodriguez RA, Hailpern SM, Larson EB, Kurella Tamura M. Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. JAMA 2010, 304:180-186. 10.1001/jama.2010.924, 20628131.
10. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant 2011, 26:1608-1614. 10.1093/ndt/gfq630, 21098012.
11. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007, 22:1955-1962. 10.1093/ndt/gfm153, 17412702.
12. Smith C, Da Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K. Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract 2003, 95:c40-c46. 10.1159/000073708, 14610329.
13. Wu VC, Wu CH, Huang TM, Wang CY, Lai CF, Shiao CC, Chang CH, Lin SL, Chen YY, Chen YM, Chu TS, Chiang WC, Wu KD, Tsai PR, Chen L, Ko WJ. Long-term risk of coronary events after AKI. J Am Soc Nephrol 2014, 25:595-605. 10.1681/ASN.2013060610, 24503241.
14. Wu IW, Wang SY, Hsu KH, Lee CC, Sun CY, Tsai CJ, Wu MS. Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality-a controlled cohort study based on the NKF/DOQI guidelines. Nephrol Dial Transplant 2009, 24:3426-3433. 10.1093/ndt/gfp259, 19491379.
15. Chen YR, Yang Y, Wang SC, Chiu PF, Chou WY, Lin CY, Chang JM, Chen TW, Ferng SH, Lin CL. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study. Nephrol Dial Transplant 2013, 28:671-682. 10.1093/ndt/gfs469, 23223224.
16. Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton) 2010, 15:3-9. 10.1111/j.1440-1797.2010.01304.x.
17. Wu CY, Chan FK, Wu MS, Kuo KN, Wang CB, Tsao CR, Lin JT. Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel. Gastroenterology 2010, 139:1165-1171. 10.1053/j.gastro.2010.06.067, 20600012.
18. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011, 20:236-242. 10.1002/pds.2087, 21351304.
19. Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc 2005, 104:157-163. 15818428.
20. Brophy DF, Daniel G, Gitlin M, Mayne TJ. Characterizing hospitalizations of end-stage renal disease patients on dialysis and inpatient utilization of erythropoiesis-stimulating agent therapy. Ann Pharmacother 2010, 44:43-49. 10.1345/aph.1M429, 20028955.
21. Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease. Ann Pharmacother 2007, 41:1761-1769. 10.1345/aph.1K194, 17895328.
22. Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia. JAMA Intern Med 2014, 174:347-354. 10.1001/jamainternmed.2013.12700, 24343093.
23. Hwang SJ, Yang WC, Lin MY, Mau LW, Chen HC. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan. Nephrol Dial Transplant 2010, 25:2616-2624. 10.1093/ndt/gfq308, 20519231.
24. Chao PW, Ou SM, Chen YT, Lee YJ, Wang FM, Liu CJ, Yang WC, Chen TJ, Chen TW, Li SY. Acute appendicitis in patients with end-stage renal disease. J Gastrointest Surg 2012, 16:1940-1946. 10.1007/s11605-012-1961-z, 22777056.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
26. O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007, 18:2758-2765. 10.1681/ASN.2007040422, 17855638.
27. Lamping DL, Constantinovici N, Roderick P, Normand C, Henderson L, Harris S, Brown E, Gruen R, Victor C. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet 2000, 356:1543-1550. 10.1016/S0140-6736(00)03123-8, 11075766.
28. Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ 1999, 318:217-223. 10.1136/bmj.318.7178.217, 9915728.
29. Holley JL, Hines SC, Glover JJ, Babrow AS, Badzek LA, Moss AH. Failure of advance care planning to elicit patients' preferences for withdrawal from dialysis. Am J Kidney Dis 1999, 33:688-693. 10.1016/S0272-6386(99)70220-9, 10196010.
30. Yang WC, Hwang SJ. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant 2008, 23:3977-3982. 10.1093/ndt/gfn406, 18628366.
31. Wu PH, Lin YT, Lee TC, Lin MY, Kuo MC, Chiu YW, Hwang SJ, Chen HC. Predicting mortality of incident dialysis patients in Taiwan - a longitudinal population-based study. PLoS One 2013, 8:e61930. 10.1371/journal.pone.0061930, 23626754.
32. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009, 361:1539-1547. 10.1056/NEJMoa0904655, 19828531.
33. Lin YT, Wu PH, Kuo MC, Lin MY, Lee TC, Chiu YW, Hwang SJ, Chen HC. High cost and low survival rate in high comorbidity incident elderly hemodialysis patients. PLoS One 2013, 8:e75318. 10.1371/journal.pone.0075318, 24040407.
34. Joly D, Anglicheau D, Alberti C, Nguyen AT, Touam M, Grunfeld JP, Jungers P. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003, 14:1012-1021. 10.1097/01.ASN.0000054493.04151.80, 12660336.
35. Carson RC, Juszczak M, Davenport A, Burns A. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease?. Clin J Am Soc Nephrol 2009, 4:1611-1619. 10.2215/CJN.00510109, 19808244.
36. Murtaugh PA, Dickson ER, Van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, Gips CH. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology 1994, 20:126-134. 10.1002/hep.1840200120, 8020881.
37. Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, Juhl E, Poulsen H, Tygstrup N. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986, 21:163-174. 10.3109/00365528609034642, 3520795.
38. Altman DG, De Stavola BL. Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Stat Med 1994, 13:301-341. 10.1002/sim.4780130402, 8177984.
39. Peters R, Beckett N, McCormack T, Fagard R, Fletcher A, Bulpitt C. Treating hypertension in the very elderly: benefits, risks, and future directions, a focus on the hypertension in the very elderly trial. Eur Heart J 2014, 35:1712-1718. 10.1093/eurheartj/eht464, 24302270.
40. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010, 363:609-619. 10.1056/NEJMoa1000552, 20581422.